Apogee Therapeutics, Inc.
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
APGE | NDAQ
Overview
Corporate Details
- ISIN(s):
- US03770N1019
- LEI:
- Country:
- United States of America
- Address:
- 221 CRESCENT ST., 2453 WALTHAM
- Website:
- https://apogeetherapeutics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Apogee Therapeutics, Inc. is a clinical-stage biotechnology company that develops therapies for immunological and inflammatory (I&I) diseases. The company's pipeline consists of novel antibody therapeutics and differentiated biologics designed to target established biological drivers. Apogee focuses on creating potentially best-in-class treatments for conditions with significant unmet needs, including dermatological, respiratory, and gastroenterological disorders like atopic dermatitis. Its scientific approach aims to develop medicines that offer improved efficacy and longer-lasting effects compared to the current standard of care, with the goal of improving the lives of patients with these chronic conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Apogee Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Apogee Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Apogee Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
